Title : Synergistic inhibition of MEK/ERK and BRAF V600E with PD98059 and PLX4032 induces sodium/iodide symporter (NIS) expression and radioiodine uptake in BRAF mutated papillary thyroid cancer cells.

Pub. Date : 2018

PMID : 30337961






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Synergistic inhibition of MEK/ERK and BRAF V600E with PD98059 and PLX4032 induces sodium/iodide symporter (NIS) expression and radioiodine uptake in BRAF mutated papillary thyroid cancer cells. 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one mitogen-activated protein kinase 1 Homo sapiens
2 Methods: BCPAP and K1 cells were exposed to increasing concentrations of BRAF V600E inhibitor PLX4032 (0.01 muM, 0.1 muM, 1 muM) or MEK/ERK inhibitor PD98059 (0.01 muM, 0.1 muM, 1 muM) or with their association or/and in the presence of 3 mM perchlorate (ClO- 4) for 0-72 h. Iodide uptake and expression of BRAF, phosphorylated (p) ERK1/2, NIS were detected. 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one mitogen-activated protein kinase 1 Homo sapiens
3 However, combined treatment of PLX4032 and PD98059 completely inhibited p-ERK expression. 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one mitogen-activated protein kinase 1 Homo sapiens